Multi-Imaging Adaptability Of Breast Biopsy Procedure
Sep 25, 2026
1. Clinical Pain Points
Most conventional breast biopsy needles have single imaging adaptability, which cannot be compatible with multi-modal imaging guidance scenarios, resulting in limited clinical application scope. Ordinary non-echogenic biopsy needles can only rely on empirical puncture under simple ultrasound, and cannot form effective imaging feedback under low-frequency ultrasound, stereotactic mammography and MRI guidance. Single-mode compatible instruments are unable to adapt to the mixed diagnosis needs of complex lesions such as tiny calcification, occult lesions and multi-dimensional heterogeneous lesions. In the process of modal switching, mismatched biopsy needles will cause blurred imaging, unclear needle body positioning and deviation of sample notch recognition, leading to repeated scanning and re-puncture. The poor universality of traditional equipment not only reduces the efficiency of multi-modal collaborative diagnosis, but also increases the difficulty of clinical operation and the rate of missed diagnosis of early breast lesions, restricting the development of high-precision composite biopsy procedures.
2. Core Working Principle
The multi-imaging adaptability of breast biopsy procedures relies on the multi-frequency echo structural design and universal metal material characteristics of high-precision biopsy needles. The 304 and 316 medical stainless steel materials have stable imaging display characteristics, which can form clear and recognizable imaging signals in ultrasound, X-ray stereotaxy and MRI environments. The multi-dimensional optimized echogenic markings on the stylet tip and cannula adopt multi-frequency compatible etching technology, which can produce uniform and high-brightness echo feedback under different imaging frequencies and modal parameters. Combined with the thin-wall uniform stress structure and linear penetration design, the needle body maintains stable posture and fixed positioning parameters in different imaging environments, avoiding imaging distortion and signal loss. This universal structural design realizes seamless adaptation of a single biopsy needle to multiple imaging guidance modes, breaking the modal limitation of traditional single-function instruments.
3. Multi-Modal Adaptable Equipment Classification
According to imaging modal adaptation performance, breast biopsy needles are divided into three universal functional types. First is full-frequency ultrasound-adaptable needles (12G–20G), with dense multi-point echogenic etching, compatible with high-frequency and low-frequency ultrasound equipment, suitable for superficial solid lesions and deep hidden lesion ultrasound-guided sampling. Second is X-ray stereotactic compatible needles, adopting high-density stainless steel enhanced imaging structure, clear display under mammography, specially used for tiny calcified lesion puncture and positioning sampling. Third is multi-modal universal integrated needles, with optimized non-magnetic structure and full-section echo design, compatible with ultrasound, stereotaxy and MRI three major modes, which is the core equipment for complex multi-modal composite biopsy diagnosis, supporting switching use of different imaging equipment in one operation.
4. Multi-Imaging Collaborative Operation Guidelines
Multi-modal adaptive breast biopsy procedures need to follow collaborative standardized operation specifications. Firstly, preoperative modal evaluation: select the optimal imaging guidance mode according to lesion type, and match the corresponding multi-adaptable biopsy needle. Secondly, equipment debugging: adjust the frequency and parameters of imaging equipment, confirm the clear display of needle body echogenic markings and lesion images, and eliminate imaging distortion. Thirdly, hierarchical positioning operation: complete preliminary lesion positioning through stereotactic X-ray, accurate depth calibration through real-time ultrasound, and confirm sampling accuracy through MRI fine scanning for complex lesions. Fourthly, modal switching control: keep the needle body stable during imaging switching, avoid position offset, and complete sampling after multi-modal joint confirmation. Finally, retain multi-group imaging data for mutual verification to ensure diagnostic accuracy.
5. Practical Multi-Modal Application Experience
Clinical multi-imaging collaborative practice shows that universal adaptive biopsy needles greatly expand the clinical application boundary of breast biopsy procedures. Compared with single-mode traditional needles, multi-modal compatible products improve the lesion positioning accuracy of composite imaging by 55%, and realize one-needle multi-purpose, avoiding repeated needle replacement and secondary trauma. For tiny calcified lesions that are difficult to display by conventional ultrasound, X-ray compatible biopsy needles can achieve accurate targeting, with a sampling qualified rate of 98.7%. For occult breast lesions with unclear single-mode imaging, multi-modal joint guidance supported by universal needles effectively reduces the early lesion missed diagnosis rate to less than 0.5%. The stable material and structural performance of medical stainless steel ensures no imaging interference and signal distortion in complex scanning environments, greatly improving the reliability of multi-modal collaborative biopsy diagnosis.
6. Summary and Sublimation
Multi-imaging adaptability is a key technical upgrade for breast biopsy procedures to develop towards composite and intelligent precision diagnosis. The universal material performance and multi-frequency echo structure of high-precision biopsy needles solve the pain points of single modal limitation, poor universality and low diagnosis efficiency of traditional biopsy equipment. The multi-modal collaborative operation mode realizes complementary advantages of different imaging technologies, covers all types of breast lesion diagnosis scenarios, and makes up for the diagnostic blind area of single guidance mode. It not only improves the accuracy and comprehensiveness of lesion sampling, but also optimizes the clinical procedural process, providing strong technical support for early and accurate diagnosis of atypical and complex breast lesions.
7. Industry Prospect and Suggestion
Multi-modal intelligent fusion diagnosis will be the core development direction of breast biopsy procedures in the future. It is suggested to further optimize the multi-frequency echo etching process of biopsy needles to improve imaging resolution under extreme parameters. Develop fully non-magnetic high-precision stainless steel biopsy products to enhance MRI scene adaptability. Build a multi-modal intelligent matching system for biopsy needles and imaging equipment to realize automatic modal identification and parameter adaptation. Standardize the clinical operation specifications of multi-imaging collaborative biopsy, form a unified composite diagnosis process system, and promote the popularization of high-efficiency and high-precision multi-modal breast biopsy technology in global high-end medical institutions.







